These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. The management of blood safety in the presence of uncertain risk: a United kingdom perspective. Watkins NA; Dobra S; Bennett P; Cairns J; Turner ML Transfus Med Rev; 2012 Jul; 26(3):238-51. PubMed ID: 22126710 [TBL] [Abstract][Full Text] [Related]
72. The American Red Cross Hemovigilance Program: advancing the safety of blood donation and transfusion. Eder AF; Dy BA; Barton J; Kennedy JM; Benjamin RJ Immunohematology; 2009; 25(4):179-85. PubMed ID: 20406027 [No Abstract] [Full Text] [Related]
73. The administration of blood components: a British Society for Haematology Guideline. Robinson S; Harris A; Atkinson S; Atterbury C; Bolton-Maggs P; Elliott C; Hawkins T; Hazra E; Howell C; New H; Shackleton T; Shreeve K; Taylor C Transfus Med; 2018 Feb; 28(1):3-21. PubMed ID: 29110357 [No Abstract] [Full Text] [Related]
74. General principles of small animal blood component administration. Kristensen AT; Feldman BF Vet Clin North Am Small Anim Pract; 1995 Nov; 25(6):1277-90. PubMed ID: 8619266 [TBL] [Abstract][Full Text] [Related]
75. [Therapy with blood components and plasma derivatives: the current cross-sectional guidelines]. Biscoping J Anaesthesist; 2009 Nov; 58(11):1083-4. PubMed ID: 19890616 [No Abstract] [Full Text] [Related]
76. Blood safety. Mant S; Smith MP N Z Med J; 2013 May; 126(1374):10-1. PubMed ID: 23799377 [No Abstract] [Full Text] [Related]
77. Research opportunities in optimizing storage of red blood cell products. Wagner SJ; Glynn SA; Welniak LA; Transfusion; 2014 Feb; 54(2):483-94. PubMed ID: 23676138 [No Abstract] [Full Text] [Related]
78. Pathogen reduced plasma products: a clinical practice scientific review from the AABB. Cushing MM; Pagano MB; Jacobson J; Schwartz J; Grossman BJ; Kleinman S; Han MA; Cohn CS; Transfusion; 2019 Sep; 59(9):2974-2988. PubMed ID: 31268584 [TBL] [Abstract][Full Text] [Related]
79. The potential for bacterial testing of blood products. Wagner SJ Zentralbl Bakteriol; 1996 Mar; 283(3):253-7. PubMed ID: 8861862 [No Abstract] [Full Text] [Related]
80. Managing recalls and withdrawals of blood components. Ramsey G Transfus Med Rev; 2004 Jan; 18(1):36-45. PubMed ID: 14689376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]